Literature DB >> 24398795

Analysis of rare variant population structure in Europeans explains differential stratification of gene-based tests.

Matthew Zawistowski1, Mark Reppell1, Daniel Wegmann2, Pamela L St Jean3, Margaret G Ehm3, Matthew R Nelson3, John Novembre4, Sebastian Zöllner5.   

Abstract

There is substantial interest in the role of rare genetic variants in the etiology of complex human diseases. Several gene-based tests have been developed to simultaneously analyze multiple rare variants for association with phenotypic traits. The tests can largely be partitioned into two classes - 'burden' tests and 'joint' tests - based on how they accumulate evidence of association across sites. We used the empirical joint site frequency spectra of rare, nonsynonymous variation from a large multi-population sequencing study to explore the effect of realistic rare variant population structure on gene-based tests. We observed an important difference between the two test classes: their susceptibility to population stratification. Focusing on European samples, we found that joint tests, which allow variants to have opposite directions of effect, consistently showed higher levels of P-value inflation than burden tests. We determined that the differential stratification was caused by two specific patterns in the interpopulation distribution of rare variants, each correlating with inflation in one of the test classes. The pattern that inflates joint tests is more prevalent in real data, explaining the higher levels of inflation in these tests. Furthermore, we show that the different sources of inflation between tests lead to heterogeneous responses to genomic control correction and the number of variants analyzed. Our results indicate that care must be taken when interpreting joint and burden analyses of the same set of rare variants, in particular, to avoid mistaking inflated P-values in joint tests for stronger signals of true associations.

Entities:  

Mesh:

Year:  2014        PMID: 24398795      PMCID: PMC4135410          DOI: 10.1038/ejhg.2013.297

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  25 in total

1.  Genomic control for association studies.

Authors:  B Devlin; K Roeder
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  FTEC: a coalescent simulator for modeling faster than exponential growth.

Authors:  Mark Reppell; Michael Boehnke; Sebastian Zöllner
Journal:  Bioinformatics       Date:  2012-03-21       Impact factor: 6.937

3.  Extending rare-variant testing strategies: analysis of noncoding sequence and imputed genotypes.

Authors:  Matthew Zawistowski; Shyam Gopalakrishnan; Jun Ding; Yun Li; Sara Grimm; Sebastian Zöllner
Journal:  Am J Hum Genet       Date:  2010-11-12       Impact factor: 11.025

4.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

5.  Marbled inflation from population structure in gene-based association studies with rare variants.

Authors:  Qianying Liu; Dan L Nicolae; Lin S Chen
Journal:  Genet Epidemiol       Date:  2013-03-06       Impact factor: 2.135

6.  Evolution and functional impact of rare coding variation from deep sequencing of human exomes.

Authors:  Jacob A Tennessen; Abigail W Bigham; Timothy D O'Connor; Wenqing Fu; Eimear E Kenny; Simon Gravel; Sean McGee; Ron Do; Xiaoming Liu; Goo Jun; Hyun Min Kang; Daniel Jordan; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; Goncalo Abecasis; David Altshuler; Deborah A Nickerson; Eric Boerwinkle; Shamil Sunyaev; Carlos D Bustamante; Michael J Bamshad; Joshua M Akey
Journal:  Science       Date:  2012-05-17       Impact factor: 47.728

7.  A geometric framework for evaluating rare variant tests of association.

Authors:  Keli Liu; Shannon Fast; Matthew Zawistowski; Nathan L Tintle
Journal:  Genet Epidemiol       Date:  2013-03-21       Impact factor: 2.135

8.  The empirical power of rare variant association methods: results from sanger sequencing in 1,998 individuals.

Authors:  Martin Ladouceur; Zari Dastani; Yurii S Aulchenko; Celia M T Greenwood; J Brent Richards
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

9.  A groupwise association test for rare mutations using a weighted sum statistic.

Authors:  Bo Eskerod Madsen; Sharon R Browning
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

10.  An evaluation of statistical approaches to rare variant analysis in genetic association studies.

Authors:  Andrew P Morris; Eleftheria Zeggini
Journal:  Genet Epidemiol       Date:  2010-02       Impact factor: 2.135

View more
  13 in total

1.  Leveraging ancestry to improve causal variant identification in exome sequencing for monogenic disorders.

Authors:  Robert Brown; Hane Lee; Ascia Eskin; Gleb Kichaev; Kirk E Lohmueller; Bruno Reversade; Stanley F Nelson; Bogdan Pasaniuc
Journal:  Eur J Hum Genet       Date:  2015-04-22       Impact factor: 4.246

2.  Determination of disease phenotypes and pathogenic variants from exome sequence data in the CAGI 4 gene panel challenge.

Authors:  Kunal Kundu; Lipika R Pal; Yizhou Yin; John Moult
Journal:  Hum Mutat       Date:  2017-06-27       Impact factor: 4.878

3.  On the substructure controls in rare variant analysis: Principal components or variance components?

Authors:  Yiwen Luo; Arnab Maity; Michael C Wu; Chris Smith; Qing Duan; Yun Li; Jung-Ying Tzeng
Journal:  Genet Epidemiol       Date:  2017-12-26       Impact factor: 2.135

4.  Exon array analysis reveals genetic heterogeneity in atypical femoral fractures. A pilot study.

Authors:  Isabel Pérez-Núñez; José L Pérez-Castrillón; María T Zarrabeitia; Carmen García-Ibarbia; Laura Martínez-Calvo; José M Olmos; Laisa S Briongos; Javier Riancho; Victoria Camarero; Josep M Muñoz Vives; Raquel Cruz; José A Riancho
Journal:  Mol Cell Biochem       Date:  2015-07-10       Impact factor: 3.396

5.  Taking population stratification into account by local permutations in rare-variant association studies on small samples.

Authors:  Jimmy Mullaert; Matthieu Bouaziz; Yoann Seeleuthner; Benedetta Bigio; Jean-Laurent Casanova; Alexandre Alcaïs; Laurent Abel; Aurélie Cobat
Journal:  Genet Epidemiol       Date:  2021-08-17       Impact factor: 2.135

6.  The role of rare variants in systolic blood pressure: analysis of ExomeChip data in HyperGEN African Americans.

Authors:  Yun Ju Sung; Jacob Basson; Nuo Cheng; Khanh-Dung H Nguyen; Priyanka Nandakumar; Steven C Hunt; Donna K Arnett; Victor G Dávila-Román; Dabeeru C Rao; Aravinda Chakravarti
Journal:  Hum Hered       Date:  2015       Impact factor: 0.444

7.  Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk.

Authors:  Kristin A Rand; Nadin Rohland; Arti Tandon; Alex Stram; Xin Sheng; Ron Do; Bogdan Pasaniuc; Alex Allen; Dominique Quinque; Swapan Mallick; Loic Le Marchand; Sam Kaggwa; Alex Lubwama; Daniel O Stram; Stephen Watya; Brian E Henderson; David V Conti; David Reich; Christopher A Haiman
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

8.  The effect of rare variants on inflation of the test statistics in case-control analyses.

Authors:  Ailith Pirie; Angela Wood; Michael Lush; Jonathan Tyrer; Paul D P Pharoah
Journal:  BMC Bioinformatics       Date:  2015-02-20       Impact factor: 3.169

9.  Progress in methods for rare variant association.

Authors:  Stephanie A Santorico; Audrey E Hendricks
Journal:  BMC Genet       Date:  2016-02-03       Impact factor: 2.797

10.  Whole-exome sequencing to analyze population structure, parental inbreeding, and familial linkage.

Authors:  Aziz Belkadi; Vincent Pedergnana; Aurélie Cobat; Yuval Itan; Quentin B Vincent; Avinash Abhyankar; Lei Shang; Jamila El Baghdadi; Aziz Bousfiha; Alexandre Alcais; Bertrand Boisson; Jean-Laurent Casanova; Laurent Abel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.